Financing ·
Solid Biosciences Inc. filed a prospectus supplement to its universal shelf registration statement on Form S-3…
SLDBSolid Biosciences Inc.
Solid Biosciences Inc. filed a prospectus supplement to its universal shelf registration statement on Form S-3, authorizing the offer and sale of up to $200.0 million in shares of common stock under an Amended and Restated Sales Agreement with Jefferies LLC. This filing supersedes a prior prospectus supplement that had authorized up to $85.0 million; approximately $85.0 million has already been issued and sold under the previous authorization, which is now closed. The company operates in the biotechnology industry, focusing on gene therapy for inherited retinal diseases.